A psychoneuroendocrine study of brain dopaminergic sensitivity in locally limited or metastatic cancer patients

In Vivo

Volumn 17, Issue 6, 2003, Pages 647-650

  Lissoni, P ^a   Messina, G ^a   Vaghi, M ^a   Bartolacelli, E ^a   Massarenti, L L ^a   Trabattoni, P ^a   Meregalli, P ^a   Meregalli, M ^a   Gavazzeni, C ^a   Rovelli, F ^a   Tancini, G ^a   Gardani, G S ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Apomorphine; Dopaminergic system; Psycho oncology

Indexed keywords

APOMORPHINE; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER; CANCER CLASSIFICATION; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LIVER METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; NEUROCHEMISTRY; NEUROENDOCRINE DISEASE; PROLACTIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; SIGNAL TRANSDUCTION; VENOUS BLOOD;

EID: 10744220189     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Rubinow DR: Brain, behaviour and immunity: An interactive system. J Natl Canc Inst Monogr 10: 79-82, 1990.
2. Klein TW, Newton C and Friedman H: Cannabinoid receptors and immunity. Immunol Today 19: 373-381, 1998.
3. Lissoni P, Cangemi P, Pirato D et al: A review on cancer-psychospiritual interactions. Neuroendocrinol Lett 22: 175-180, 2001.
4. Lissoni P, Resentini M, Mauri R et al: Effects of tetrahydrocannabinol on melatonin secretion in man. Horm Metab Res 18: 77-78, 1986.
5. Rotrosen J, Angrist B, Gershon S et al: Neuroendocrine effects of apomorphine. Br J Psychiatry 135: 444-456, 1979.
6. Surmann A and Havemann-Reinecke U: Injection of apomorphine: A test to predict individual different dopaminergic sensitivity? J Neural Transm Suppl 45: 143-145, 1995.
7. Lissoni P, Malugani F, Manganini V et al: Psychoncology and cancer progression-related alterations of pleasure-associated neurochemical system. Neuroendocrinol Lett, in press.
8. Vijayan E and Mc Cann SM: The effect of systemic administration of dopamine and apomorphine on plasma LH and prolactin concentrations in conscious rats. Neuroendocrinology 25: 221-235, 1978.
9. Bartsch C, Bartsch H and Lippert TH: The pineal gland and cancer: Facts, hypotheses and perspectives. Cancer J 5: 194-199, 1992.
10. Lissoni P, Barni S, Paolorossi F et al: Evidence for altered opioid activity in patients with cancer. Br J Cancer 56: 384-387, 1987.
11. Kondo Y, Imai Y, Hojo H, Endo T and Nozoe S: Suppression of tumor cell growth and mitogen response by apomorphine alkaloids, dicentrine, glaucine, corydine and apomorphine. J Pharmacobiodyn 13: 426-431, 1990.